Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial

Table 1

Phakic patients: descriptive statistics.

Group I age	Group II age	value	Number of patients	Group I	Group II
58.24 years ± 9.24 years	56.32 ± 11.1 years	0.48	N = patients	56	49
Parameter	Preoperative value		value	Postoperative values		value
	Group I	Group II		Group I	Group II
IOP (mm Hg)	30.5 ± 4.0	29.3 ± 3.11	0.87	15.34 ± 2.34	14.10 ± 3.20	0.58
CDVA (logMAR)	0.48 ± 0.31	0.42 ± 0.24	0.72	0.44 ± 0.25	0.40 ± 0.26	0.42
Diurnal IOP	4.47 ± 2.32	3.50 ± 1.40	0.77	2.13 ± 0.89	1.72 ± 0.5	0.56
Number of medications	3.22 ± 1.1	3.10 ± 1.48	0.85	0.11 ± 0.04	0.12 ± 0.03	0.54
Duration of medicine use	6.35 ± 4.25 years	4.56 ± 5.23 years	0.32

Group I: 24 males and 32 females; Group II: 29 males and 20 females.